Germany's Merck KGaA has struck a deal to buy U.S. biotech company SpringWorks Therapeutics for an equity value of $3.9 ...

Alembic Pharma received the final approval from the USFDA for its abbreviated new drug application (ANDA) for Carbamazepine ...

Orthocell has received its third regulatory approval for April after getting the green light to sell its flagship nerve repair ... Read More The post Orthocell secures third global approval in April ...